Skip to content
Screener

Microbot Medical MBOT Q1 2026 earnings

Reported May 13, 2026 · After market close

Revenue$105.0KMiss by $195.0K
EPS-$0.05Beat by $0.03
Revenue estimate$300.0K
EPS estimate-$0.08

Next report

Nov 11, 2026 (in 2 months)
Revenue estimate$566.7K
EPS estimate-$0.09

Financials

Q1 2026

Income statement

See full
Revenue$105.0K—
Gross profit$2.0K—
Operating income-$4.3M-43.0%
Net income-$3.7M-41.1%
EPS (diluted)-$0.05+37.5%

Balance sheet

See full
Cash & equivalents$3.7M+13.7%
Total debt$898.0K+551%
Total equity$74.1M+156%
Total assets$78.1M+153%

Cash flow

See full
Operating cash flow-$5.1M-75.8%
CapEx$108.0K+731%
Free cash flow-$5.2M-78.8%

Valuation & ratios

Valuation

as of 03/31/26
See full
Market cap$161.85M+208%
Enterprise value$159.09M+222%

Returns & leverage

See full
Return on equity-27.6%-10.2pp
Debt / equity0×0.0×
Current ratio22.6×+6.4×

FAQ

When did Microbot Medical report Q1 2026 earnings?
Microbot Medical (MBOT) reported Q1 2026 earnings on May 13, 2026 after market close.
What were Microbot Medical's Q1 2026 revenue and EPS?
Microbot Medical reported revenue of $105.0K and eps of $-0.05 for Q1 2026.
Did Microbot Medical beat estimates in Q1 2026?
Revenue missed the consensus estimate of $300.0K by $195.0K. EPS beat the consensus estimate of $-0.08 by $0.03.
How did Microbot Medical's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 37.5% from $-0.08.
Where can I find Microbot Medical's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001493152-26-022886) and the 10-Q periodic report (0001493152-26-022792) directly on SEC EDGAR. The filing index links above go to sec.gov.